EIR Par Pharmaceuticals Jan 2007

Thao Kwan FDA, Caryn Mcnab FDA, Kim Thomas Cruse FDA$595.00 - Available Now

FDA investigators audited the Par Pharmaceuticals - Irvine, CA, United States facility and issued inspectional observation (via FDA 483) on 22 Jan 2007.

Product details

  • Category:
  • Inspection end: 22 Jan 2007
  • Location: Irvine, United States
  • FEI: 3004492248
Add To Cart